PharmaVentures
PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors.
Our key offerings include:
Transactions / deal negotiations;
Product / technology valuations;
Deal term advice;
Due diligence & expert reports;
Strategy formulation;
Alliance management; and
Expert opinion for litigation/arbitration cases.
PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.
Pfizer
Pfizer Inc. (Pfizer), incorporated on June 2, 1942, is a research-based, global biopharmaceutical company. The Company operates in two segments: Biopharmaceutical and Diversified. Biopharmaceutical includes the Primary Care, Specialty Care, Established Products, Emerging Markets and Oncology customer-focused units, which includes products that prevent and treat cardiovascular and metabolic diseases , central nervous system disorders , arthritis and pain , respiratory diseases , urogenital conditions , cancer , eye disease and endocrine disorders , among others. Diversified includes Animal Health products; Consumer Healthcare products, such as pain management therapies, cough / cold / allergy remedies, dietary supplements, hemorrhoidal care and other personal care items; Nutrition products such as infant and toddler formula products, and Capsugel. On January 31, 2011, it acquired approximately 92.5% of King's common stock. In August 2011, the Company sold its Capsugel business to an affiliate of Kohlberg Kravis Roberts & Co. L.P.